Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›Smart›LIV
LIV

Smart Healthcare Innovation ETF

The LIV Exchange Traded Fund (ETF) is provided by Smart. It is built to track an index: STOXX Global Breakthrough Healthcare Index. The dividend policy is capitalization.

Advertisement

Advertisement

NZ$3.65
-NZ$0.008 (-0.22%) yesterday
11:04 PM 07/15/26 Open
1D price range
NZ$3.65NZ$3.65
52W price range
NZ$2.88NZ$3.86
YTD Perf.
+7.06%
YTD Flows
Annualized volatility
Fund AuM
€13M
Share class AuM
€13M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
NZLIVE0008S6
TER
0.75%
Inception date
6/6/2019
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 14, 2026
-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
99.55%
Unavailable
0.29%
Other
0.14%
Latest LIV news

No content available for this fund

FAQ about LIV

LIV is a Passive ETF. This ETF provides exposure to Other Equities.
LIV tracks the STOXX Global Breakthrough Healthcare Index - USD, through a replication method.
LIV carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.
LIV was introduced to the market on June 6, 2019. It trades on New Zealand
Smart Healthcare Innovation ETF, LIV, is provided by Smart. Learn more about Smart here.
LIV oversees €13M in assets as of July 14, 2026.
LIV follows a capitalizing, meaning it reinvests income within the fund.
As of May 31, 2026, LIV has significant geographic allocations in USA, Switzerland and Republic of Korea.
As of May 31, 2026, LIV focuses largely on Healthcare.
As of May 31, 2026, LIV holds 168 positions in its portfolio, with 31.24% of assets concentrated in its top 15 holdings.
As of May 31, 2026, LIV top three holdings include Illumina, Inc., UCB SA and Moderna, Inc..
The base currency of LIV is NZD.
Data as of 05/31/26
Illumina, Inc.
2.83%
UCB SA
2.38%
Moderna, Inc.
2.26%
Merck & Co., Inc.
2.23%
Biogen, Inc.
2.21%
Johnson & Johnson
2.20%
Natera, Inc.
2.06%
Guardant Health, Inc.
1.99%
Novartis AG
1.94%
Neurocrine Biosciences, Inc.
1.94%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight